Gujarat Kidney And Super Speciality Approves Wholly Owned Subsidiary and Leadership Changes
Gujarat Kidney And Super Speciality Limited, formerly known as Gujarat Kidney And Superspeciality Private Limited and previously Vihaan Medicare Private Limited, announced key approvals following its Board of Directors meeting held on April 27, 2026. The company approved the incorporation of a Wholly Owned Subsidiary (WOS) aimed at expanding healthcare services in Bharuch, Gujarat.The incorporation of the WOS was further sanctioned by the Shareholders via Postal Ballot concluded on April 25, 2026. This initiative seeks to cater to the growing need for healthcare services in the Bharuch District, supplementing the medical care facilities currently provided by the company in locations like Vadodara, Dahod, Ahmedabad, and Godhara.
In connection with the proposed WOS, the company confirmed that the entity would be a related party. The WOS company will be initially incorporated with a nominal capital of Rs 1,00,000, divided into 10,000 equity shares of Rs 10 each. Gujarat Kidney And Super Speciality Limited will subscribe these 10,000 shares along with its Nominees, achieving 100% holding in the proposed WOS. The company plans to subscribe the shares in cash and will invest further funds into the WOS in tranches based on legal requirements.
Key Approvals and Appointments
The Board meeting addressed several corporate governance and operational matters:Management Appointments:
The Board of Directors approved the appointment of Ms. Vishakha Mahesh Phadke as the Company Secretary and Compliance Officer, effective from April 27, 2026. Ms. Phadke is an Associate Member of the Institute of Company Secretaries of India (Membership No. A 37675) and possesses expertise in Company Secretarial Functions, Statutory Compliance, and Corporate Governance.
Shareholder Resolutions:
The Board also took note of the resolutions passed by the Shareholders through the Postal Ballot, covering vital operational and financial approvals:
| Resolution | Type of Approval | Purpose |
|---|---|---|
| To consider and approve the Interim utilization of Funds towards healthcare expansion aligned with the Company's Main IPO object. | Special Resolution | Financial Utilization |
| To approve voluntary revision of Financial Statements and Boards report under section 131 of Companies Act 2013 | Special Resolution | Financial Reporting |
| To appoint Mr Dharmendra Bhaliya, Practising Company Secretary, as Secretarial Auditors of the Company for FY 2025-26 | Ordinary Resolution | Statutory Appointment |
The Board Meeting commenced at 5:00 P.M. and concluded at 06:15 P.M.
GKSL Stock Price Movement
Today, Gujarat Kidney And Super Speciality Limited shares gained, closing at ₹115.44 after rising 1.83% for the session. The stock finished its trading day on a volume of 741,416 shares, recovering from a day low of ₹112.01.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.